Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Background: Autism is a neurodevelopmental disorder characterized by impairments in social interaction and deficits in verbal and nonverbal communication, together with the presence of repetitive behaviors or a limited repertoire of activities and interests. The causes of autism are currently unclear. In a previous study, we determined that 21% of children with autism have plasma autoantibodies that are immunoreactive with a population of neurons in the cerebellum that appear to be Golgi cells, which are GABAergic interneurons. Methods: We have extended this analysis by examining plasma immunoreactivity in the remainder of the brain. To determine cell specificity, double-labeling studies that included one of the calcium-binding proteins that are commonly colocalized in GABAergic neurons (calbindin, parvalbumin or calretinin) were also carried out to determine which GABAergic neurons are immunoreactive. Coronal sections through the rostrocaudal extent of the macaque monkey brain were reacted with plasma from each of seven individuals with autism who had previously demonstrated positive Golgi cell staining, as well as six negative controls. In addition, brain sections from adult male mice were similarly examined. Results: In each case, specific staining was observed for neurons that had the morphological appearance of interneurons. By double-labeling sections with plasma and with antibodies directed against γ-aminobutyric acid (GABA), we determined that all autoantibody-positive neurons were GABAergic. However, not all GABAergic neurons were autoantibody-positive. Calbindin was colabeled in several of the autoantibody-labeled cells, while parvalbumin colabeling was less frequently observed. Autoantibody-positive cells rarely expressed calretinin. Sections from the mouse brain processed similarly to the primate sections also demonstrated immunoreactivity to interneurons distributed throughout the neocortex and many subcortical regions. Some cell populations stained in the primate (such as the Golgi neurons in the cerebellum) were not as robustly immunoreactive in the mouse brain. Conclusions: These results suggest that the earlier report of autoantibody immunoreactivity to specific cells in the cerebellum extend to other regions of the brain. Further, these findings confirm the autoantibody-targeted cells to be a subpopulation of GABAergic interneurons. The potential impact of these autoantibodies on GABAergic disruption with respect to the etiology of autism is discussed herein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Model of autism: increased ratio of excitation/inhibition in key neural systems
Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768 · cited 1×
“The potential imbalance of excitatory and inhibitory neurotransmission in autism could influence cortical networks that control social behaviors and neuromodulatory systems [55].”
BackgroundNeuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 1×
“There is provocative evidence for an ongoing inflammatory response in some individuals with autism [8,9].”
BackgroundAmaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 1×
“However, it is now clear that autism affects many brain regions [27], and the question arises whether the autoantibodies present in autistic individuals identify a broader class of neurons that are distributed throughout the brain.”
BackgroundSelf-citationAutism screening questionnaire: diagnostic validity
Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.5.444 · Cited by 1,464 · cited 1×
“The Social Communication Questionnaire [32] was used to screen for characteristics of ASD among the typically developing controls.”
MethodDeFelipe, J. (1997) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(97)10013-8 · Cited by 550
The immune response in autism: a new frontier for autism research
Ashwood, P., Wills, S., & Van de Water, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205707 · Cited by 528 · cited 1×
“Several studies have shown peripheral immune abnormalities in patients with autism [5-7].”
BackgroundSelf-citationCognitive profiles and social‐communicative functioning in children with autism spectrum disorder
Joseph, R. M., Tager‐Flusberg, H., & Lord, C. (2002) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00092 · Cited by 503 · cited 4×
“The final ASD status is defined as meeting criteria on the communication, social interaction and repetitive behavior domains of the ADIR with onset prior to 36 months of age and scoring at or above the social plus communication cutoff for autism on the ADOS module 1 or 2.”
BackgroundInfluentialFatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., & Realmuto, G. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01430-0 · Cited by 500
GABAA Receptor Downregulation in Brains of Subjects with Autism
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., & Thuras, P. D. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0646-7 · Cited by 439
Stereological Analysis of Amygdala Neuron Number in Autism
Schumann, C. M., & Amaral, D. G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1285-06.2006 · Cited by 413 · cited 1×
“While a decreased number of neurons has been reported in the amygdala [77] and in the fusiform gyrus [78] of postmortem cases of autism, it is not yet clear whether there is a preferential loss of any particular category of neurons, such as GABAergic interneurons.”
BackgroundSelf-citationBlatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., & Bauman, M. L. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013238809666 · Cited by 322 · cited 2×
“[66] examined the distribution and density”
BackgroundNeurochemical correlates of autistic disorder: a review of the literature
Lam, K. S. L., Aman, M. G., & Arnold, L. E. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2005.03.003 · Cited by 318
Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications
Yip, J., Soghomonian, J.-J., & Blatt, G. J. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0176-3 · Cited by 303
Mechanisms of postnatal neurobiological development: Implications for human development
Webb, S. J., Monk, C. S., & Nelson, C. A. (2001) · Developmental Neuropsychology · doi:10.1207/s15326942dn1902_2 · Cited by 272
Neurons in the fusiform gyrus are fewer and smaller in autism
van Kooten, I. A. J., Palmen, S. J. M. C., von Cappeln, P., Steinbusch, H. W. M., Korr, H., Heinsen, H., Hof, P. R., van Engeland, H., & Schmitz, C. (2008) · Brain · doi:10.1093/brain/awn033 · Cited by 263
Hussman, J. P. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1010715619091 · Cited by 263 · cited 2×
“Interestingly, a reduction in GABAergic activity is also capable of causing epilepsy, which has been reported in up to one-third of individuals with ASD [52,56-60].”
BackgroundCirculating autoantibodies to neuronal and glial filament proteins in autism
Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00045-3 · Cited by 234
Reduced Natural Killer Cell Activity in Autism
WARREN, R. P., FOSTER, A., & MARGARETTEN, N. C. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198705000-00008 · Cited by 190 · cited 1×
“Converging evidence over the past 40 years indicates that immune dysfunction may be an important factor contributing to the development of a subset of cases of autism [2-4].”
BackgroundIs autism an autoimmune disease?
Ashwood, P., & Van de Water, J. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.07.036 · Cited by 181
Self-citationMolecular mechanisms of autism: a possible role for Ca2+ signaling
Krey, J. F., & Dolmetsch, R. E. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.01.010 · Cited by 169
Wills, S., Cabanlit, M., Bennett, J., Ashwood, P., Amaral, D. G., & Van de Water, J. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.007 · Cited by 163 · cited 3×
“The current study was designed to be a detailed follow-up of our previous study that described the presence of Golgi cell immunoreactivity in the plasma of a subpopulation of children with autism [26].”
BackgroundMethodResultSelf-citationBrain‐Specific Autoantibodies in the Plasma of Subjects with Autistic Spectrum Disorder
CABANLIT, M., WILLS, S., GOINES, P., ASHWOOD, P., & VAN DE WATER, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1381.010 · Cited by 157
Self-citationThe autism‐epilepsy connection
Levisohn, P. M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01399.x · Cited by 146
The organization of the transcriptional network in specific neuronal classes
Winden, K. D., Oldham, M. C., Mirnics, K., Ebert, P. J., Swan, C. H., Levitt, P., Rubenstein, J. L., Horvath, S., & Geschwind, D. H. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.46 · Cited by 112 · cited 1×
“However, recent neuronal transcriptome studies [49,50] have made it abundantly clear that tens to hundreds of proteins differentiate neuronal classes.”
BackgroundPrevalence of serum antibodies to caudate nucleus in autistic children
Singh, V. K., & Rivas, W. H. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.10.026 · Cited by 108 · cited 1×
“These include glial and neuron-axon filament proteins [15] (but see [16]), myelin basic protein [17] (but see [18]), serotonin receptor [19], nerve growth factor [20], cerebellar peptides [21], brain-derived neurotrophic factor [22], brain endothelial cells [23] and the caudate nucleus [24].”
BackgroundProbing the transcriptome of neuronal cell types
Nelson, S. B., Hempel, C., & Sugino, K. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.08.006 · Cited by 92 · cited 1×
“However, recent neuronal transcriptome studies [49,50] have made it abundantly clear that tens to hundreds of proteins differentiate neuronal classes.”
Background
Cited by
Consensus Paper: Pathological Role of the Cerebellum in Autism
Fatemi, S. H., Aldinger, K. A., Ashwood, P., Bauman, M. L., Blaha, C. D., Blatt, G. J., Chauhan, A., Chauhan, V., Dager, S. R., Dickson, P. E., et al. (2012) · The Cerebellum · doi:10.1007/s12311-012-0355-9 · Cited by 723
Self-citationThe role of immune dysfunction in the pathophysiology of autism
Onore, C., Careaga, M., & Ashwood, P. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.08.007 · Cited by 635
Self-citationXu, X., Wells, A. B., O'Brien, D. R., Nehorai, A., & Dougherty, J. D. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4488-13.2014 · Cited by 282
Cerebral folate receptor autoantibodies in autism spectrum disorder
Frye, R. E., Sequeira, J. M., Quadros, E. V., James, S. J., & Rossignol, D. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.175 · Cited by 255
Piras, I. S., Haapanen, L., Napolioni, V., Sacco, R., Van de Water, J., & Persico, A. M. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.12.020 · Cited by 88
Metadata
- Authors
- Wills, S., Rossi, C. C., Bennett, J., Martinez-Cerdeño, V., Ashwood, P., Amaral, D. G., & Van de Water, J.
- Venue
- Molecular Autism
- Published
- 2011-04-26
- Volume
- 2
- Issue
- 1
- Pages
- 5-5
- ISSN
- 2040-2392 (ISSN-L)
- OpenAlex
- W2108454970
- Cited by
- 53
- References
- 26
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.